Danske Bank A/S Insmed Inc Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$96.14 - $147.2 $230,736 - $353,280
2,400 New
2,400 $345,000
Q2 2025

Dec 18, 2025
BUY
$64.81 - $105.9 $136,101 - $222,390
2,100 Added 700.0%
2,400 $241,000
Q1 2025

Dec 18, 2025
SELL
$65.25 - $83.83 $137,025 - $176,043
-2,100 Reduced 87.5%
300 $22,000

Others Institutions Holding INSM

# of Institutions
659
Shares Held
208M
Call Options Held
3.83M
Put Options Held
4.26M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email